B cell biomarkers of rituximab responses in systemic lupus erythematosus

Abstract

Our findings indicate that rituximab is effective in SLE, and clinical responses are supported by close correlation with B cell numbers. HSFC is a valuable tool in the assessment and prediction of response in SLE.